Ladenburg Thalmann Assumes Elicio Therapeutics (ELTX) at Buy Following Selloff, 'overblown'
Tweet Send to a Friend
(Updated - June 18, 2026 7:33 AM EDT)
Ladenburg Thalmann analyst Kevin DeGeeter assumes coverage on Elicio Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Ladenburg Thalmann analyst Kevin DeGeeter assumes coverage on Elicio Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
